2018年12月1-4日，第60届美国血液学年会（ASH）将于美国·圣地亚哥隆重召开。每年的ASH无疑是众咖齐聚、精彩纷呈。随着中国肿瘤医学的发展，越来越多的中国学者相继登上这个顶级盛会的舞台。今年，将有哪些“中国声音”入选ASH口头报告呢？跟随小编一起来看看吧！
当地时间：12月1日
72 Myeloid-Derived Suppressor Cells (HLA-DR-/lowCD16-CD33+) Expanded By Granulocyte Colony-Stimulating Factor Can Prevent Acute Graft-Versus-Host Disease in Humanized Mouse and Patients Following HSCT
讲者：北京大学血液学研究所 王柯
时间：12月1日 8:45 AM
地点：Grand Hall B (Manchester Grand Hyatt San Diego)
链接：https://ash.confex.com/ash/2018/webprogram/Paper114291.html
76 Endothelial O-Glycoproteins Cooperate with Platelet CLEC-2 Signaling to Maintain Cerebrovascular Integrity during Mouse Development
讲者：苏州大学附属第一医院 傅建新
时间：12月1日 10:15 AM
地点：Room 28D (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper118929.html
148 Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial
讲者：北京大学肿瘤医院 宋玉琴
时间：12月1日 12:45 PM
地点：Pacific Ballroom 20 (Marriott Marquis San Diego Marina)
链接：https://ash.confex.com/ash/2018/webprogram/Paper117956.html
212 The Novel Berbamine Derivative, Cbbm, Downregulates c-Myc to Block Diffuse Large B-Cell Lymphoma Cell Maintenance
讲者：浙江大学医学院附属邵逸夫医院 张蕾
时间：12月1日 2:15 PM
地点：Room 7B (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper112006.html
192 High Expression of NEK2 Mediated By p53 Contributes to Progression and Relapse of Multiple Myeloma
讲者：中国医学科学院北京协和医学院血液学研究所 周文
时间：12月1日 3:15 PM
地点：Grand Ballroom 7 (Marriott Marquis San Diego Marina)
链接：https://ash.confex.com/ash/2018/webprogram/Paper116155.html
199 A Novel Recombinant Human Thrombopoietin Therapy for Promoting Platelet Engraftment in Haematological Malignancies after Single Umbilical Cord Blood Transplantation: A Prospective Randomized Controlled Trial
讲者：中国科技大学附属第一医院 朱小玉
时间：12月1日 2:00 PM
地点：Grand Hall B (Manchester Grand Hyatt San Diego)
链接：https://ash.confex.com/ash/2018/webprogram/Paper118195.html
当地时间：12月2日
277 A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia
讲者：陆道培医院 陆佩华
时间：12月2日7:30 AM
地点：Ballroom 20D (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper114415.html
280 Efficacy and Safety of CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphocytic Leukemia (B-cell ALL) in a Large Cohort Including Patients with Extramedullary Disease(EMD), High Leukemia Burden, BCR-ABL (+) Mutation,TP53 Mutation, and Post-Transplant Relapse
讲者：陆道培医院 张弦
时间：12月2日 8:15 AM
地点：Ballroom 20D (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper115642.html
360 Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection
讲者：北京大学血液学研究所 余星星
时间：12月2日10:45 AM
地点：Grand Hall A (Manchester Grand Hyatt San Diego)
链接：https://ash.confex.com/ash/2018/webprogram/Paper115772.html
当地时间：12月3日
682 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study
讲者：北京大学肿瘤医院 宋玉琴
时间：12月3日11:15 AM
地点：Room 6F (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper117848.html
727 First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation
讲者：北京大学血液学研究所 赵翔宇
时间：12月3日 2:45 PM
地点：Room 8 (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper113923.html
791 Safety and Efficacy of HQP1351, a 3rd Generation Oral BCR-ABL Inhibitor in Patients with Tyrosine Kinase Inhibitor -Resistant Chronic Myelogenous Leukemia: Preliminary Results of Phase I Study
讲者：北京大学血液学研究所 江倩
时间：12月3日 3:45 PM
地点：Room 6E (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper119142.html
901 First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial
讲者：成都总医院造血干细胞移植中心 刘芳
时间：12月3日 4:30 PM
地点：Seaport Ballroom F (Manchester Grand Hyatt San Diego)
链接：https://ash.confex.com/ash/2018/webprogram/Paper110579.html
955 Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma
讲者：西安交大附属二院 赵万红
时间：12月3日4:30 PM
地点：Ballroom 20A (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper110548.html
956 Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma
讲者：上海恒润达生生物科技有限公司 刘雅容
时间：12月3日 4:45 PM
地点：Ballroom 20A (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper112786.html
960 Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma
讲者：温州医科大学附属第一医院 江松福
时间：12月3日 5:45 PM
地点：Ballroom 20A (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper113220.html
1009 Tandom Autologous Transplantation and Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for High Risk MM: Initial Safety and Efficacy Report from a Clinical Pilot Study
讲者：苏州大学附属第一医院 傅琤琤
时间：12月3日 6:15 PM
地点：Ballroom 20D (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper117964.html
1013 T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies
讲者：华中科技大学同济医学院同济医院 李春蕊
时间：12月3日 7:15 PM
地点：Ballroom 20D (San Diego Convention Center)
链接：https://ash.confex.com/ash/2018/webprogram/Paper116898.html
欢迎大家持续追踪后续报道。如有遗漏，敬请留言补充！
欲了解更多血液肿瘤、淋巴瘤相关资讯，与全国各地血液肿瘤、淋巴瘤医生交流与讨论，请扫描以下二维码，添加肿瘤资讯-娜小编，备注“血液肿瘤”！
苏公网安备32059002004080号
